Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor
NCT07140393Phase 2Recruiting
- Sponsor
- Hengrui
- Start
- Oct 2025
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-4508 in solid tumor, sponsored by Hengrui. Started Oct 2025; status: recruiting.
02
Drugs
HRS-4508
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07140393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07140393.